NASDAQ:IMACIMAC Stock Price, Forecast & News

IMAC's stock was trading at $0.82 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, IMAC stock has increased by 97.6% and is now trading at $1.62. View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IMAC in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for IMAC.

IMAC is scheduled to release its next quarterly earnings announcement on Friday, August 21st 2020. View our earnings forecast for IMAC.

IMAC Holdings Inc (NASDAQ:IMAC) released its earnings results on Thursday, May, 14th. The company reported ($0.18) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by $0.01. The firm earned $3.32 million during the quarter, compared to the consensus estimate of $5.72 million. IMAC had a negative net margin of 41.20% and a negative return on equity of 80.08%. View IMAC's earnings history.

2 equities research analysts have issued 1 year target prices for IMAC's stock. Their forecasts range from $4.50 to $4.50. On average, they expect IMAC's share price to reach $4.50 in the next year. This suggests a possible upside of 177.8% from the stock's current price. View analysts' price targets for IMAC.

Media headlines about IMAC stock have trended negative recently, according to InfoTrie. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. IMAC earned a daily sentiment score of -2.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutIMAC.

IMAC saw a decline in short interest in May. As of May 15th, there was short interest totaling 46,800 shares, a decline of 45.8% from the April 30th total of 86,400 shares. Based on an average daily trading volume, of 1,070,000 shares, the short-interest ratio is currently 0.0 days. Currently, 0.9% of the company's stock are sold short. View IMAC's Current Options Chain.

Some companies that are related to IMAC include Acadia Healthcare (ACHC), BioTelemetry (BEAT), Hanger (HNGR), Biocorrx (BICX) and AAC (AAC). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other IMAC investors own include NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Amarin (AMRN), VBI Vaccines (VBIV), Advanced Micro Devices (AMD), Aytu Bioscience (AYTU), Crispr Therapeutics (CRSP), Vaxart (VXRT), Agile Therapeutics (AGRX) and Armata Pharmaceuticals (ARMP).

(IMAC) raised $4 million in an initial public offering (IPO) on the week of February 11th 2019. The company issued 900,000 shares at $5.00 per share. Dawson James Securities and Cuttone acted as the underwriters for the IPO.

IMAC trades on the NASDAQ under the ticker symbol "IMAC."

Shares of IMAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of IMAC stock can currently be purchased for approximately $1.62.

IMAC has a market capitalization of $16.21 million and generates $15.13 million in revenue each year. The company earns $-6,500,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis.

The official website for IMAC is www.imacregeneration.com.

IMAC's mailing address is 1605 WESTGATE CIRCLE, BRENTWOOD TN, 37027. The company can be reached via phone at 844-266-4622 or via email at [email protected]